ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Liposomal Formulation Development Service Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-14L16857
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Liposomal Formulation Development Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
BUY CHAPTERS

Global Liposomal Formulation Development Service Market Research Report 2025

Code: QYRE-Auto-14L16857
Report
August 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Creative-Biolabs
Evonik
Genevant Sciences
Nippon Fine Chemical
Corden Pharma
Acuitas Therapeutics
Cytiva
Croda International
Merck KGaA
Polymun Scientific
GenScript
WuXi STA
MicroNano Biologics
Precigenome
Catalent
Wacker
Detai Biotechnology
Waters
Carcell

Liposomal Formulation Development Service Market Size

The global market for Liposomal Formulation Development Service was valued at US$ 501 million in the year 2024 and is projected to reach a revised size of US$ 1220 million by 2031, growing at a CAGR of 12.3% during the forecast period.

Liposomal Formulation Development Service Market

Liposomal Formulation Development Service Market

Liposomal Formulation Development Service refers to a specialized pharmaceutical development service that focuses on designing, optimizing, and producing liposome-based drug delivery systems. These services typically include lipid selection, formulation design, encapsulation of active pharmaceutical ingredients (APIs), characterization (e.g., size, zeta potential, encapsulation efficiency), stability studies, scale-up, and technology transfer. Liposomal formulations enhance drug bioavailability, control release profiles, reduce toxicity, and improve targeting, making them widely used in oncology, vaccines, anti-infectives, and gene therapies.
The global market for liposomal formulation development is experiencing strong momentum, primarily fueled by the commercialization of mRNA vaccines, expansion of RNA-based therapeutic pipelines, and rising demand for long-acting drug delivery systems. The COVID-19 pandemic served as a catalyst, accelerating both investment and infrastructure buildup in lipid-based delivery technologies.
A notable trend is the shift from fragmented service offerings to fully integrated solutions, where clients seek partners who can deliver not only formulation design but also lipid raw materials, process scale-up, analytical method development, GMP manufacturing, and regulatory support. Leading CDMOs like Evonik, Polymun Scientific, and Corden Pharma have expanded capabilities through acquisition and facility upgrades, particularly in aseptic fill-finish and lipid excipient production.
In the raw materials space, high-purity synthetic lipids remain a high-barrier segment, dominated by players such as Nippon Fine Chemical and Croda (via Avanti Polar Lipids). These companies maintain IP-secured production processes and cater primarily to North American and European innovators. While emerging suppliers in China and India are entering the market, they face challenges in GMP compliance, analytical robustness, and IP clearance.
On the application side, liposomes have evolved from classical cancer and vaccine applications to now include siRNA, mRNA, and CRISPR therapies. This has prompted a wave of innovation in ionizable lipid design and formulation optimization. Clients are increasingly looking for service providers capable of custom lipid synthesis aligned with delivery goals, aiming to improve drug efficacy and batch-to-batch consistency.
Looking forward, the liposomal formulation market is expected to maintain double-digit growth over the next 3–5 years. The sector is becoming increasingly IP-driven and quality-intensive, with successful players needing to demonstrate expertise across formulation science, process engineering, lipid chemistry, and regulatory compliance. The continued approval of nucleic acid therapeutics will reinforce demand for specialized CDMOs and lipid excipient suppliers with deep technical foundations.
This report aims to provide a comprehensive presentation of the global market for Liposomal Formulation Development Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposomal Formulation Development Service.
The Liposomal Formulation Development Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Liposomal Formulation Development Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liposomal Formulation Development Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Liposomal Formulation Development Service Market Report

Report Metric Details
Report Name Liposomal Formulation Development Service Market
Accounted market size in year US$ 501 million
Forecasted market size in 2031 US$ 1220 million
CAGR 12.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Small Molecules
  • Proteins
  • Peptides
  • Nucleic Acids
  • Others
Segment by Application
  • Gene Therapy
  • Vaccine
  • Cancer Treatment
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Cytiva, Croda International, Evonik, Merck KGaA, Genevant Sciences, Nippon Fine Chemical, Polymun Scientific, Corden Pharma, Acuitas Therapeutics, Creative Biolabs, GenScript, WuXi STA, MicroNano Biologics, Precigenome, Catalent, Wacker, Detai Biotechnology, Waters, Carcell
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Liposomal Formulation Development Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Liposomal Formulation Development Service Market growing?

Ans: The Liposomal Formulation Development Service Market witnessing a CAGR of 12.3% during the forecast period 2025-2031.

What is the Liposomal Formulation Development Service Market size in 2031?

Ans: The Liposomal Formulation Development Service Market size in 2031 will be US$ 1220 million.

Who are the main players in the Liposomal Formulation Development Service Market report?

Ans: The main players in the Liposomal Formulation Development Service Market are Cytiva, Croda International, Evonik, Merck KGaA, Genevant Sciences, Nippon Fine Chemical, Polymun Scientific, Corden Pharma, Acuitas Therapeutics, Creative Biolabs, GenScript, WuXi STA, MicroNano Biologics, Precigenome, Catalent, Wacker, Detai Biotechnology, Waters, Carcell

What are the Application segmentation covered in the Liposomal Formulation Development Service Market report?

Ans: The Applications covered in the Liposomal Formulation Development Service Market report are Gene Therapy, Vaccine, Cancer Treatment

What are the Type segmentation covered in the Liposomal Formulation Development Service Market report?

Ans: The Types covered in the Liposomal Formulation Development Service Market report are Small Molecules, Proteins, Peptides, Nucleic Acids, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liposomal Formulation Development Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Small Molecules
1.2.3 Proteins
1.2.4 Peptides
1.2.5 Nucleic Acids
1.2.6 Others
1.3 Market by Application
1.3.1 Global Liposomal Formulation Development Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Gene Therapy
1.3.3 Vaccine
1.3.4 Cancer Treatment
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liposomal Formulation Development Service Market Perspective (2020-2031)
2.2 Global Liposomal Formulation Development Service Growth Trends by Region
2.2.1 Global Liposomal Formulation Development Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Liposomal Formulation Development Service Historic Market Size by Region (2020-2025)
2.2.3 Liposomal Formulation Development Service Forecasted Market Size by Region (2026-2031)
2.3 Liposomal Formulation Development Service Market Dynamics
2.3.1 Liposomal Formulation Development Service Industry Trends
2.3.2 Liposomal Formulation Development Service Market Drivers
2.3.3 Liposomal Formulation Development Service Market Challenges
2.3.4 Liposomal Formulation Development Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liposomal Formulation Development Service Players by Revenue
3.1.1 Global Top Liposomal Formulation Development Service Players by Revenue (2020-2025)
3.1.2 Global Liposomal Formulation Development Service Revenue Market Share by Players (2020-2025)
3.2 Global Top Liposomal Formulation Development Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Liposomal Formulation Development Service Revenue
3.4 Global Liposomal Formulation Development Service Market Concentration Ratio
3.4.1 Global Liposomal Formulation Development Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liposomal Formulation Development Service Revenue in 2024
3.5 Global Key Players of Liposomal Formulation Development Service Head office and Area Served
3.6 Global Key Players of Liposomal Formulation Development Service, Product and Application
3.7 Global Key Players of Liposomal Formulation Development Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Liposomal Formulation Development Service Breakdown Data by Type
4.1 Global Liposomal Formulation Development Service Historic Market Size by Type (2020-2025)
4.2 Global Liposomal Formulation Development Service Forecasted Market Size by Type (2026-2031)
5 Liposomal Formulation Development Service Breakdown Data by Application
5.1 Global Liposomal Formulation Development Service Historic Market Size by Application (2020-2025)
5.2 Global Liposomal Formulation Development Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Liposomal Formulation Development Service Market Size (2020-2031)
6.2 North America Liposomal Formulation Development Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Liposomal Formulation Development Service Market Size by Country (2020-2025)
6.4 North America Liposomal Formulation Development Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Liposomal Formulation Development Service Market Size (2020-2031)
7.2 Europe Liposomal Formulation Development Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Liposomal Formulation Development Service Market Size by Country (2020-2025)
7.4 Europe Liposomal Formulation Development Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Liposomal Formulation Development Service Market Size (2020-2031)
8.2 Asia-Pacific Liposomal Formulation Development Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Liposomal Formulation Development Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Liposomal Formulation Development Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Liposomal Formulation Development Service Market Size (2020-2031)
9.2 Latin America Liposomal Formulation Development Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Liposomal Formulation Development Service Market Size by Country (2020-2025)
9.4 Latin America Liposomal Formulation Development Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liposomal Formulation Development Service Market Size (2020-2031)
10.2 Middle East & Africa Liposomal Formulation Development Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Liposomal Formulation Development Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Liposomal Formulation Development Service Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cytiva
11.1.1 Cytiva Company Details
11.1.2 Cytiva Business Overview
11.1.3 Cytiva Liposomal Formulation Development Service Introduction
11.1.4 Cytiva Revenue in Liposomal Formulation Development Service Business (2020-2025)
11.1.5 Cytiva Recent Development
11.2 Croda International
11.2.1 Croda International Company Details
11.2.2 Croda International Business Overview
11.2.3 Croda International Liposomal Formulation Development Service Introduction
11.2.4 Croda International Revenue in Liposomal Formulation Development Service Business (2020-2025)
11.2.5 Croda International Recent Development
11.3 Evonik
11.3.1 Evonik Company Details
11.3.2 Evonik Business Overview
11.3.3 Evonik Liposomal Formulation Development Service Introduction
11.3.4 Evonik Revenue in Liposomal Formulation Development Service Business (2020-2025)
11.3.5 Evonik Recent Development
11.4 Merck KGaA
11.4.1 Merck KGaA Company Details
11.4.2 Merck KGaA Business Overview
11.4.3 Merck KGaA Liposomal Formulation Development Service Introduction
11.4.4 Merck KGaA Revenue in Liposomal Formulation Development Service Business (2020-2025)
11.4.5 Merck KGaA Recent Development
11.5 Genevant Sciences
11.5.1 Genevant Sciences Company Details
11.5.2 Genevant Sciences Business Overview
11.5.3 Genevant Sciences Liposomal Formulation Development Service Introduction
11.5.4 Genevant Sciences Revenue in Liposomal Formulation Development Service Business (2020-2025)
11.5.5 Genevant Sciences Recent Development
11.6 Nippon Fine Chemical
11.6.1 Nippon Fine Chemical Company Details
11.6.2 Nippon Fine Chemical Business Overview
11.6.3 Nippon Fine Chemical Liposomal Formulation Development Service Introduction
11.6.4 Nippon Fine Chemical Revenue in Liposomal Formulation Development Service Business (2020-2025)
11.6.5 Nippon Fine Chemical Recent Development
11.7 Polymun Scientific
11.7.1 Polymun Scientific Company Details
11.7.2 Polymun Scientific Business Overview
11.7.3 Polymun Scientific Liposomal Formulation Development Service Introduction
11.7.4 Polymun Scientific Revenue in Liposomal Formulation Development Service Business (2020-2025)
11.7.5 Polymun Scientific Recent Development
11.8 Corden Pharma
11.8.1 Corden Pharma Company Details
11.8.2 Corden Pharma Business Overview
11.8.3 Corden Pharma Liposomal Formulation Development Service Introduction
11.8.4 Corden Pharma Revenue in Liposomal Formulation Development Service Business (2020-2025)
11.8.5 Corden Pharma Recent Development
11.9 Acuitas Therapeutics
11.9.1 Acuitas Therapeutics Company Details
11.9.2 Acuitas Therapeutics Business Overview
11.9.3 Acuitas Therapeutics Liposomal Formulation Development Service Introduction
11.9.4 Acuitas Therapeutics Revenue in Liposomal Formulation Development Service Business (2020-2025)
11.9.5 Acuitas Therapeutics Recent Development
11.10 Creative Biolabs
11.10.1 Creative Biolabs Company Details
11.10.2 Creative Biolabs Business Overview
11.10.3 Creative Biolabs Liposomal Formulation Development Service Introduction
11.10.4 Creative Biolabs Revenue in Liposomal Formulation Development Service Business (2020-2025)
11.10.5 Creative Biolabs Recent Development
11.11 GenScript
11.11.1 GenScript Company Details
11.11.2 GenScript Business Overview
11.11.3 GenScript Liposomal Formulation Development Service Introduction
11.11.4 GenScript Revenue in Liposomal Formulation Development Service Business (2020-2025)
11.11.5 GenScript Recent Development
11.12 WuXi STA
11.12.1 WuXi STA Company Details
11.12.2 WuXi STA Business Overview
11.12.3 WuXi STA Liposomal Formulation Development Service Introduction
11.12.4 WuXi STA Revenue in Liposomal Formulation Development Service Business (2020-2025)
11.12.5 WuXi STA Recent Development
11.13 MicroNano Biologics
11.13.1 MicroNano Biologics Company Details
11.13.2 MicroNano Biologics Business Overview
11.13.3 MicroNano Biologics Liposomal Formulation Development Service Introduction
11.13.4 MicroNano Biologics Revenue in Liposomal Formulation Development Service Business (2020-2025)
11.13.5 MicroNano Biologics Recent Development
11.14 Precigenome
11.14.1 Precigenome Company Details
11.14.2 Precigenome Business Overview
11.14.3 Precigenome Liposomal Formulation Development Service Introduction
11.14.4 Precigenome Revenue in Liposomal Formulation Development Service Business (2020-2025)
11.14.5 Precigenome Recent Development
11.15 Catalent
11.15.1 Catalent Company Details
11.15.2 Catalent Business Overview
11.15.3 Catalent Liposomal Formulation Development Service Introduction
11.15.4 Catalent Revenue in Liposomal Formulation Development Service Business (2020-2025)
11.15.5 Catalent Recent Development
11.16 Wacker
11.16.1 Wacker Company Details
11.16.2 Wacker Business Overview
11.16.3 Wacker Liposomal Formulation Development Service Introduction
11.16.4 Wacker Revenue in Liposomal Formulation Development Service Business (2020-2025)
11.16.5 Wacker Recent Development
11.17 Precigenome
11.17.1 Precigenome Company Details
11.17.2 Precigenome Business Overview
11.17.3 Precigenome Liposomal Formulation Development Service Introduction
11.17.4 Precigenome Revenue in Liposomal Formulation Development Service Business (2020-2025)
11.17.5 Precigenome Recent Development
11.18 Detai Biotechnology
11.18.1 Detai Biotechnology Company Details
11.18.2 Detai Biotechnology Business Overview
11.18.3 Detai Biotechnology Liposomal Formulation Development Service Introduction
11.18.4 Detai Biotechnology Revenue in Liposomal Formulation Development Service Business (2020-2025)
11.18.5 Detai Biotechnology Recent Development
11.19 Waters
11.19.1 Waters Company Details
11.19.2 Waters Business Overview
11.19.3 Waters Liposomal Formulation Development Service Introduction
11.19.4 Waters Revenue in Liposomal Formulation Development Service Business (2020-2025)
11.19.5 Waters Recent Development
11.20 Carcell
11.20.1 Carcell Company Details
11.20.2 Carcell Business Overview
11.20.3 Carcell Liposomal Formulation Development Service Introduction
11.20.4 Carcell Revenue in Liposomal Formulation Development Service Business (2020-2025)
11.20.5 Carcell Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Creative-Biolabs
Evonik
Genevant Sciences
Nippon Fine Chemical
Corden Pharma
Acuitas Therapeutics
Cytiva
Croda International
Merck KGaA
Polymun Scientific
GenScript
WuXi STA
MicroNano Biologics
Precigenome
Catalent
Wacker
Detai Biotechnology
Waters
Carcell
List of Tables
 Table 1. Global Liposomal Formulation Development Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Small Molecules
 Table 3. Key Players of Proteins
 Table 4. Key Players of Peptides
 Table 5. Key Players of Nucleic Acids
 Table 6. Key Players of Others
 Table 7. Global Liposomal Formulation Development Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Liposomal Formulation Development Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Liposomal Formulation Development Service Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Liposomal Formulation Development Service Market Share by Region (2020-2025)
 Table 11. Global Liposomal Formulation Development Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Liposomal Formulation Development Service Market Share by Region (2026-2031)
 Table 13. Liposomal Formulation Development Service Market Trends
 Table 14. Liposomal Formulation Development Service Market Drivers
 Table 15. Liposomal Formulation Development Service Market Challenges
 Table 16. Liposomal Formulation Development Service Market Restraints
 Table 17. Global Liposomal Formulation Development Service Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Liposomal Formulation Development Service Market Share by Players (2020-2025)
 Table 19. Global Top Liposomal Formulation Development Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomal Formulation Development Service as of 2024)
 Table 20. Ranking of Global Top Liposomal Formulation Development Service Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Liposomal Formulation Development Service Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Liposomal Formulation Development Service, Headquarters and Area Served
 Table 23. Global Key Players of Liposomal Formulation Development Service, Product and Application
 Table 24. Global Key Players of Liposomal Formulation Development Service, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Liposomal Formulation Development Service Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Liposomal Formulation Development Service Revenue Market Share by Type (2020-2025)
 Table 28. Global Liposomal Formulation Development Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Liposomal Formulation Development Service Revenue Market Share by Type (2026-2031)
 Table 30. Global Liposomal Formulation Development Service Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Liposomal Formulation Development Service Revenue Market Share by Application (2020-2025)
 Table 32. Global Liposomal Formulation Development Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Liposomal Formulation Development Service Revenue Market Share by Application (2026-2031)
 Table 34. North America Liposomal Formulation Development Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Liposomal Formulation Development Service Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Liposomal Formulation Development Service Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Liposomal Formulation Development Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Liposomal Formulation Development Service Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Liposomal Formulation Development Service Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Liposomal Formulation Development Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Liposomal Formulation Development Service Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Liposomal Formulation Development Service Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Liposomal Formulation Development Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Liposomal Formulation Development Service Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Liposomal Formulation Development Service Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Liposomal Formulation Development Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Liposomal Formulation Development Service Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Liposomal Formulation Development Service Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Cytiva Company Details
 Table 50. Cytiva Business Overview
 Table 51. Cytiva Liposomal Formulation Development Service Product
 Table 52. Cytiva Revenue in Liposomal Formulation Development Service Business (2020-2025) & (US$ Million)
 Table 53. Cytiva Recent Development
 Table 54. Croda International Company Details
 Table 55. Croda International Business Overview
 Table 56. Croda International Liposomal Formulation Development Service Product
 Table 57. Croda International Revenue in Liposomal Formulation Development Service Business (2020-2025) & (US$ Million)
 Table 58. Croda International Recent Development
 Table 59. Evonik Company Details
 Table 60. Evonik Business Overview
 Table 61. Evonik Liposomal Formulation Development Service Product
 Table 62. Evonik Revenue in Liposomal Formulation Development Service Business (2020-2025) & (US$ Million)
 Table 63. Evonik Recent Development
 Table 64. Merck KGaA Company Details
 Table 65. Merck KGaA Business Overview
 Table 66. Merck KGaA Liposomal Formulation Development Service Product
 Table 67. Merck KGaA Revenue in Liposomal Formulation Development Service Business (2020-2025) & (US$ Million)
 Table 68. Merck KGaA Recent Development
 Table 69. Genevant Sciences Company Details
 Table 70. Genevant Sciences Business Overview
 Table 71. Genevant Sciences Liposomal Formulation Development Service Product
 Table 72. Genevant Sciences Revenue in Liposomal Formulation Development Service Business (2020-2025) & (US$ Million)
 Table 73. Genevant Sciences Recent Development
 Table 74. Nippon Fine Chemical Company Details
 Table 75. Nippon Fine Chemical Business Overview
 Table 76. Nippon Fine Chemical Liposomal Formulation Development Service Product
 Table 77. Nippon Fine Chemical Revenue in Liposomal Formulation Development Service Business (2020-2025) & (US$ Million)
 Table 78. Nippon Fine Chemical Recent Development
 Table 79. Polymun Scientific Company Details
 Table 80. Polymun Scientific Business Overview
 Table 81. Polymun Scientific Liposomal Formulation Development Service Product
 Table 82. Polymun Scientific Revenue in Liposomal Formulation Development Service Business (2020-2025) & (US$ Million)
 Table 83. Polymun Scientific Recent Development
 Table 84. Corden Pharma Company Details
 Table 85. Corden Pharma Business Overview
 Table 86. Corden Pharma Liposomal Formulation Development Service Product
 Table 87. Corden Pharma Revenue in Liposomal Formulation Development Service Business (2020-2025) & (US$ Million)
 Table 88. Corden Pharma Recent Development
 Table 89. Acuitas Therapeutics Company Details
 Table 90. Acuitas Therapeutics Business Overview
 Table 91. Acuitas Therapeutics Liposomal Formulation Development Service Product
 Table 92. Acuitas Therapeutics Revenue in Liposomal Formulation Development Service Business (2020-2025) & (US$ Million)
 Table 93. Acuitas Therapeutics Recent Development
 Table 94. Creative Biolabs Company Details
 Table 95. Creative Biolabs Business Overview
 Table 96. Creative Biolabs Liposomal Formulation Development Service Product
 Table 97. Creative Biolabs Revenue in Liposomal Formulation Development Service Business (2020-2025) & (US$ Million)
 Table 98. Creative Biolabs Recent Development
 Table 99. GenScript Company Details
 Table 100. GenScript Business Overview
 Table 101. GenScript Liposomal Formulation Development Service Product
 Table 102. GenScript Revenue in Liposomal Formulation Development Service Business (2020-2025) & (US$ Million)
 Table 103. GenScript Recent Development
 Table 104. WuXi STA Company Details
 Table 105. WuXi STA Business Overview
 Table 106. WuXi STA Liposomal Formulation Development Service Product
 Table 107. WuXi STA Revenue in Liposomal Formulation Development Service Business (2020-2025) & (US$ Million)
 Table 108. WuXi STA Recent Development
 Table 109. MicroNano Biologics Company Details
 Table 110. MicroNano Biologics Business Overview
 Table 111. MicroNano Biologics Liposomal Formulation Development Service Product
 Table 112. MicroNano Biologics Revenue in Liposomal Formulation Development Service Business (2020-2025) & (US$ Million)
 Table 113. MicroNano Biologics Recent Development
 Table 114. Precigenome Company Details
 Table 115. Precigenome Business Overview
 Table 116. Precigenome Liposomal Formulation Development Service Product
 Table 117. Precigenome Revenue in Liposomal Formulation Development Service Business (2020-2025) & (US$ Million)
 Table 118. Precigenome Recent Development
 Table 119. Catalent Company Details
 Table 120. Catalent Business Overview
 Table 121. Catalent Liposomal Formulation Development Service Product
 Table 122. Catalent Revenue in Liposomal Formulation Development Service Business (2020-2025) & (US$ Million)
 Table 123. Catalent Recent Development
 Table 124. Wacker Company Details
 Table 125. Wacker Business Overview
 Table 126. Wacker Liposomal Formulation Development Service Product
 Table 127. Wacker Revenue in Liposomal Formulation Development Service Business (2020-2025) & (US$ Million)
 Table 128. Wacker Recent Development
 Table 129. Precigenome Company Details
 Table 130. Precigenome Business Overview
 Table 131. Precigenome Liposomal Formulation Development Service Product
 Table 132. Precigenome Revenue in Liposomal Formulation Development Service Business (2020-2025) & (US$ Million)
 Table 133. Precigenome Recent Development
 Table 134. Detai Biotechnology Company Details
 Table 135. Detai Biotechnology Business Overview
 Table 136. Detai Biotechnology Liposomal Formulation Development Service Product
 Table 137. Detai Biotechnology Revenue in Liposomal Formulation Development Service Business (2020-2025) & (US$ Million)
 Table 138. Detai Biotechnology Recent Development
 Table 139. Waters Company Details
 Table 140. Waters Business Overview
 Table 141. Waters Liposomal Formulation Development Service Product
 Table 142. Waters Revenue in Liposomal Formulation Development Service Business (2020-2025) & (US$ Million)
 Table 143. Waters Recent Development
 Table 144. Carcell Company Details
 Table 145. Carcell Business Overview
 Table 146. Carcell Liposomal Formulation Development Service Product
 Table 147. Carcell Revenue in Liposomal Formulation Development Service Business (2020-2025) & (US$ Million)
 Table 148. Carcell Recent Development
 Table 149. Research Programs/Design for This Report
 Table 150. Key Data Information from Secondary Sources
 Table 151. Key Data Information from Primary Sources
 Table 152. Authors List of This Report


List of Figures
 Figure 1. Liposomal Formulation Development Service Picture
 Figure 2. Global Liposomal Formulation Development Service Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Liposomal Formulation Development Service Market Share by Type: 2024 VS 2031
 Figure 4. Small Molecules Features
 Figure 5. Proteins Features
 Figure 6. Peptides Features
 Figure 7. Nucleic Acids Features
 Figure 8. Others Features
 Figure 9. Global Liposomal Formulation Development Service Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Liposomal Formulation Development Service Market Share by Application: 2024 VS 2031
 Figure 11. Gene Therapy Case Studies
 Figure 12. Vaccine Case Studies
 Figure 13. Cancer Treatment Case Studies
 Figure 14. Liposomal Formulation Development Service Report Years Considered
 Figure 15. Global Liposomal Formulation Development Service Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Liposomal Formulation Development Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Liposomal Formulation Development Service Market Share by Region: 2024 VS 2031
 Figure 18. Global Liposomal Formulation Development Service Market Share by Players in 2024
 Figure 19. Global Liposomal Formulation Development Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 20. The Top 10 and 5 Players Market Share by Liposomal Formulation Development Service Revenue in 2024
 Figure 21. North America Liposomal Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Liposomal Formulation Development Service Market Share by Country (2020-2031)
 Figure 23. United States Liposomal Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Liposomal Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Liposomal Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Liposomal Formulation Development Service Market Share by Country (2020-2031)
 Figure 27. Germany Liposomal Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Liposomal Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Liposomal Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Liposomal Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Liposomal Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Ireland Liposomal Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Liposomal Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Liposomal Formulation Development Service Market Share by Region (2020-2031)
 Figure 35. China Liposomal Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Liposomal Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Liposomal Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Liposomal Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Liposomal Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia & New Zealand Liposomal Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Liposomal Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Liposomal Formulation Development Service Market Share by Country (2020-2031)
 Figure 43. Mexico Liposomal Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Liposomal Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Liposomal Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Liposomal Formulation Development Service Market Share by Country (2020-2031)
 Figure 47. Israel Liposomal Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Liposomal Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Liposomal Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Cytiva Revenue Growth Rate in Liposomal Formulation Development Service Business (2020-2025)
 Figure 51. Croda International Revenue Growth Rate in Liposomal Formulation Development Service Business (2020-2025)
 Figure 52. Evonik Revenue Growth Rate in Liposomal Formulation Development Service Business (2020-2025)
 Figure 53. Merck KGaA Revenue Growth Rate in Liposomal Formulation Development Service Business (2020-2025)
 Figure 54. Genevant Sciences Revenue Growth Rate in Liposomal Formulation Development Service Business (2020-2025)
 Figure 55. Nippon Fine Chemical Revenue Growth Rate in Liposomal Formulation Development Service Business (2020-2025)
 Figure 56. Polymun Scientific Revenue Growth Rate in Liposomal Formulation Development Service Business (2020-2025)
 Figure 57. Corden Pharma Revenue Growth Rate in Liposomal Formulation Development Service Business (2020-2025)
 Figure 58. Acuitas Therapeutics Revenue Growth Rate in Liposomal Formulation Development Service Business (2020-2025)
 Figure 59. Creative Biolabs Revenue Growth Rate in Liposomal Formulation Development Service Business (2020-2025)
 Figure 60. GenScript Revenue Growth Rate in Liposomal Formulation Development Service Business (2020-2025)
 Figure 61. WuXi STA Revenue Growth Rate in Liposomal Formulation Development Service Business (2020-2025)
 Figure 62. MicroNano Biologics Revenue Growth Rate in Liposomal Formulation Development Service Business (2020-2025)
 Figure 63. Precigenome Revenue Growth Rate in Liposomal Formulation Development Service Business (2020-2025)
 Figure 64. Catalent Revenue Growth Rate in Liposomal Formulation Development Service Business (2020-2025)
 Figure 65. Wacker Revenue Growth Rate in Liposomal Formulation Development Service Business (2020-2025)
 Figure 66. Precigenome Revenue Growth Rate in Liposomal Formulation Development Service Business (2020-2025)
 Figure 67. Detai Biotechnology Revenue Growth Rate in Liposomal Formulation Development Service Business (2020-2025)
 Figure 68. Waters Revenue Growth Rate in Liposomal Formulation Development Service Business (2020-2025)
 Figure 69. Carcell Revenue Growth Rate in Liposomal Formulation Development Service Business (2020-2025)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Liposome Development and Manufacturing Service Market Research Report 2025
Global Formulation Development Service Market Research Report 2025
Lipidomics Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liposomal DDS Technology Market Research Report 2025
Liposome Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Discovery and Development Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liposomal Supplements Market Research Report 2025
Global Liposomal Kit Market Research Report 2025
Oral Solid Dosage Formulation Development Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Sterile Formulation Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Transdermal Drug Delivery Formulation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmaceuticals Lipids Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liposomal Vitamins and Supplements Market Research Report 2025
Pharmaceutical Lipids Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liposome Extruder Market Research Report 2025
Global Cosmetics Development and Formulation Market Research Report 2024
Mini Program Development Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lipid Nanoparticle Development Service Market Research Report 2024
Global SaaS Development Service Market Research Report 2024
Global SAP Development Service Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions